The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model
Open accessAbstract
Brain derived neurotrophic factor (BDNF) promotes the growth, differentiation, maintenance and survival of neurons. These attributes make BDNF a potentially powerful therapeutic agent. However, its charge, instability in blood, and poor blood brain barrier (BBB) penetrability have impeded its development. Here, we show that engineered clathrin triskelia (CT) conjugated to BDNF (BDNF-CT) and delivered intranasally increased hippocampal BDNF concentrations 400-fold above that achieved previously with intranasal BDNF alone. We also show that BDNF-CT targeted Tropomyosin receptor kinase B (TrkB) and increased TrkB expression and downstream signaling in iTat mouse brains. Mice were induced to conditionally express neurotoxic HIV Transactivator-of-Transcription (Tat) protein that decreases BDNF. Down-regulation of BDNF is correlated with increased severity of HIV/neuroAIDS. BDNF-CT enhanced neurorestorative effects in the hippocampus including newborn cell proliferation and survival, granule cell neurogenesis, synaptogenesis and increased dendritic integrity. BDNF-CT exerted cognitive-enhancing effects by reducing Tat-induced learning and memory deficits. These results show that CT bionanoparticles efficiently deliver BDNF to the brain, making them potentially powerful tools in regenerative medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 CT efficiently delivered BDNF to TrkB receptors in the mouse brain. Tat+ mice were given a single dose of i.n. BDNF-CT-Rho (0.3 mg/kg of BDNF and 2.4 mg/kg of CT). Brains were collected after 4 h. Brain sections were probed for TrkB and visualized using Alexa Fluor 488. Confocal microscopy shows TrkB receptors (green) (a, b) and intranasally delivered BDNF-CT-Rho (red) nanoparticles (c, d). BDNF-CT-Rho are co-localized with TrkB receptors (yellow) (e, f). Images were taken from two DG locations (box; g, h). Scale bars are 2 µm. Representative images of the BDNF-CT-Rho are shown in the frontal cortex (FC) (i), striatum (STR) (j), hippocampus (HPC) (k), and hypothalamus (HTH) (l). Brains were also collected from Tat+ mice at 2, 4, and 24 h after i.n. [3]H-BDNF-CT NP administration. Tissue concentrations of radioactive [3]H-BDNF-CT were assessed. The peak concentrations of BDNF-CT in the FC (m), ST (n), HPC (o), and HTH (p) were achieved 4 h after administration. Data are represented as the mean % of the injected dose per gram (% ID/g) of tissue (n = 3/group and for 24 h n = 2/group). Error bars represent S.E.M. The scale bar is 50 µm.](https://figures.cochat.ai/paper-figures/b09ec3ce58834213ac02265a9049d3eb/clathrin-nanoparticles-deliver-bdnf-to-hippocampus-and-enhance-neurogenesis-figure-2.jpg)






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant BDNF performs poorly in humans due to rapid degradation, limited brain penetration, and unstable exposure profiles [122,123,125].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [125]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Ki-67 protein: From the known and the unknown
Scholzen, T., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3<311::aid-jcp1>3.0.co;2-9 · Cited by 4,646
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
The novel object recognition memory: neurobiology, test procedure, and its modifications
Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
Regulation of Cell Survival by Secreted Proneurotrophins
Lee, R., Kermani, P., Teng, K. K., & Hempstead, B. L. (2001) · Science · doi:10.1126/science.1065057 · Cited by 1,670
Long-Lasting Neurotrophin-Induced Enhancement of Synaptic Transmission in the Adult Hippocampus
Kang, H., & Schuman, E. M. (1995) · Science · doi:10.1126/science.7886457 · Cited by 1,354
Patterson, S. L., Abel, T., Deuel, T. A. S., Martin, K. C., Rose, J. C., & Kandel, E. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80140-3 · Cited by 1,233
Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,188
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
Paterson, R. W., Brown, R. L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., Jayaseelan, D. L., Kumar, G., Raftopoulos, R. E., Zambreanu, L., et al. (2020) · Brain · doi:10.1093/brain/awaa240 · Cited by 1,124
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034
Cited by
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
Toader, C., Șerban, M., Munteanu, O., Covache-Busuioc, R.-A., Enyedi, M., Ciurea, A. V., & Tătaru, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094271 · Cited by 175
The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Pisani, A., Paciello, F., VECCHIO, V. D., Malesci, R., Corso, E. D., Cantone, E., & Fetoni, A. R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040652 · Cited by 137
The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases
Qiu, Y., Huang, S., Peng, L., Yang, L., Zhang, G., Liu, T., Yan, F., & Peng, X. (2025) · MedComm · doi:10.1002/mco2.70213 · Cited by 113
Yang, Y., Wang, X., Xiao, A., Han, J., Wang, Z., & Wen, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.998292 · Cited by 79
“Studies have shown that BDNF can induce DCX expression, and promote neurogenesis and reparation of neurons (Vitaliano et al., 2022; Xue et al., 2022).”
BackgroundAlberto, M., Paiva‐Santos, A. C., Veiga, F., & Pires, P. C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122742 · Cited by 74
Metadata
- Authors
- Vitaliano, G. D., Kim, J. K., Kaufman, M. J., Adam, C. W., Zeballos, G., Shanmugavadivu, A., Subburaju, S., McLaughlin, J. P., Lukas, S. E., & Vitaliano, F.
- Affiliations
- Harvard University (US)
- McLean Hospital (US)
- University of Florida (US)
- Boston Consulting Group (United States) (US)
- Corresponding author
- Vitaliano, Gordana D.
- ORCID
- Venue
- Communications Biology
- Published
- 2022-03-17
- Volume
- 5
- Issue
- 1
- Pages
- 236-236
- ISSN
- 2399-3642 (ISSN-L)
- PMC
- PMC8931075
- OpenAlex
- W4221027885
- Cited by
- 48
- References
- 133
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 11 · 2023: 9 · 2022: 7
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Communications Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R44MH10848)
- U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R44DA044050, K08DA037465, T32DA015036, R01DA039044)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, intranasal drug delivery, HIV-associated neurocognitive disorders, HIV-1 Tat protein, hippocampus, neurogenesis, synaptogenesis, TrkB signaling, cognitive enhancement, blood-brain barrier, bionanoparticles
- MeSH terms
- Animals, Clathrin, Cognition, Drugs, Chinese Herbal, Hippocampus, HIV Infections, Brain-Derived Neurotrophic Factor, Mice, Nanoparticles, Neurogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model. https://app.cochat.ai/papers/10.1038/s42003-022-03177-3
- The paper
- Vitaliano, G. D., Kim, J. K., Kaufman, M. J., Adam, C. W., Zeballos, G., Shanmugavadivu, A., Subburaju, S., McLaughlin, J. P., Lukas, S. E., & Vitaliano, F. (2022). Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model. Communications Biology. https://doi.org/10.1038/s42003-022-03177-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.